Search

6 results for “Pague Menos

ANVISA Revokes Ban, Clearing Path for Mercado Livre, iFood to Enter Brazil’s $4 Billion Digital Pharmacy Market
PROTechAug 11

ANVISA Revokes Ban, Clearing Path for Mercado Livre, iFood to Enter Brazil’s $4 Billion Digital Pharmacy Market

Brazil's health regulator ANVISA revoked measures blocking medicine sales on marketplaces, opening a R$20 billion e-commerce front.

Pague Menos Posts Record 6.5% EBITDA Margin for Q2 2026, But Financial Costs and SSS Slowdown Temper Net Income Growth
InvestingAug 04

Pague Menos Posts Record 6.5% EBITDA Margin for Q2 2026, But Financial Costs and SSS Slowdown Temper Net Income Growth

Brazilian pharmacy chain Pague Menos (PGMN3) hit a record operational margin in 2Q26, though rising financial expenses and slower same-store sales growth limited net income.

Pague Menos Posts Record 6.5% EBITDA Margin Despite Sales Miss, Driven by Efficiency Gains
PROMarketsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin Despite Sales Miss, Driven by Efficiency Gains

Brazilian pharmacy chain Pague Menos (PGMN3) achieved a record 6.5% adj. EBITDA margin in Q2 2026, defying a 9.3% sales miss.

Pague Menos Posts Record 6.5% EBITDA Margin and Cuts Financial Leverage to 1.8x in Q2 2026
MarketsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin and Cuts Financial Leverage to 1.8x in Q2 2026

Pague Menos (PGMN3) reported a record 6.5% Adjusted EBITDA margin, driving net income up 22.2% in Q2, while leverage dropped for the 12th consecutive quarter.

Pague Menos Posts Record 6.5% EBITDA Margin on Extrafarma Synergies, Surpasses R$1 Billion in Digital Sales
Small CapsAug 04

Pague Menos Posts Record 6.5% EBITDA Margin on Extrafarma Synergies, Surpasses R$1 Billion in Digital Sales

Brazilian pharmaceutical retailer Pague Menos (PGMN3) reports strong 2Q26 earnings, driven by integration success and digital growth.

Mercado Livre Ozempic Deal Sparks Overdone Drugstore Selloff
InvestingJul 01

Mercado Livre Ozempic Deal Sparks Overdone Drugstore Selloff

Brazilian pharmacy stocks RD Saúde and Pague Menos fell on Mercado Livre's Mexican GLP-1 deal, but analysts say strict domestic regulations protect local players.